Putnam Investments’s 10x Genomics TXG Stock Holding History

Putnam Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.56M	Buy	+63,589	New	+$2.77M	﹤0.01%	544
2022 Q1	–	Sell	-91,028	Closed	-$13.6M	–	1260
2021 Q4	$13.6M	Sell	91,028 -6,260	-6%	-$959K	0.02%	312
2021 Q3	$14.2M	Sell	97,288 -5,695	-6%	-$978K	0.02%	293
2021 Q2	$20.2M	Buy	102,983 +68,102	+195%	+$12.3M	0.03%	244
2021 Q1	$6.31M	Sell	34,881 -760	-2%	-$131K	0.01%	456
2020 Q4	$5.05M	Sell	35,641 -674	-2%	-$97.8K	0.01%	498
2020 Q3	$4.53M	Buy	+36,315	New	+$3.81M	0.01%	501

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Putnam Investments's TXG Position: Q4 2023 in Review

Putnam Investments opened a new position in 10x Genomics (TXG) in Q4 2023: 63,589 shares worth $3.56M. The stake represents ﹤0.01% of the portfolio and ranks #544 among its holdings. This is a return to the name: Putnam Investments previously reported a position in TXG as recently as Q4 2021.

Putnam Investments first reported a position in TXG in Q3 2020 and has held it in 7 quarters since. The position peaked at $20.2M in Q2 2021. 275 funds tracked by Wall St. Rank hold TXG as of Q4 2023.

Putnam Investments held 63,589 shares of 10x Genomics worth $3.56M as of Q4 2023.
10x Genomics was a new Putnam Investments position in Q4 2023.
10x Genomics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #544 holding.
Putnam Investments first reported a position in 10x Genomics in Q3 2020 and has held it in 7 quarters since.
Putnam Investments's 10x Genomics position peaked at $20.2M in Q2 2021.
275 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.